SEVERANCE AGREEMENTSeverance Agreement • October 19th, 2012 • Chelsea Therapeutics International, Ltd. • Biological products, (no disgnostic substances) • North Carolina
Contract Type FiledOctober 19th, 2012 Company Industry JurisdictionTHIS SEVERANCE AGREEMENT (the “Agreement”) is effective as of October 16, 2012 (the “Effective Date”), by and between Chelsea Therapeutics International, Ltd., a Delaware corporation with its principal place of business in Charlotte, North Carolina (the “Company”), and Joseph Oliveto (“Executive”).